Page last updated: 2024-11-05

n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine and Infarction, Middle Cerebral Artery

n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine has been researched along with Infarction, Middle Cerebral Artery in 8 studies

N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine: a zinc ion chelating agent; structure given in first source
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine : An N-substituted diamine that is ethylenediamine in which the four amino hydrogens are replaced by 2-pyridylmethyl groups.

Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.

Research Excerpts

ExcerptRelevanceReference
"Our findings reveal a novel mechanism of cerebral ischemia-induced BBB damage, and implicate zinc as an effective and viable new target for reducing acute BBB damage following ischemic stroke."1.43Zinc contributes to acute cerebral ischemia-induced blood-brain barrier disruption. ( Dong, W; Ji, X; Liang, J; Liu, KJ; Luo, Y; Pan, R; Qi, Z; Shen, J; Shi, W; Yang, Y; Zhao, Y, 2016)
"In a rat transient middle cerebral artery occlusion (MCAO) model, the infarction volume, which is related to the neurotoxicity of glutamate, increased rapidly on the intracerebral ventricular injection of CaEDTA 30 min prior to occlusion."1.33Protective effect of zinc against ischemic neuronal injury in a middle cerebral artery occlusion model. ( Abe, J; Igarashi, K; Iida, Y; Kasuya, F; Kitamura, Y; Mifune, M; Ohta, M; Saito, Y; Saji, H; Ueda, M, 2006)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's7 (87.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhong, YH1
Dhawan, J1
Kovoor, JA1
Sullivan, J1
Zhang, WX1
Choi, D1
Biegon, A1
Zhao, Y4
Yan, F2
Yin, J2
Pan, R3
Shi, W3
Qi, Z4
Fang, Y1
Huang, Y1
Li, S2
Luo, Y4
Ji, X4
Liu, KJ4
Yan, Y1
Lee, JY1
Oh, SB1
Hwang, JJ1
Suh, N1
Jo, DG1
Kim, JS1
Koh, JY1
Dong, W2
Liang, J2
Wang, WM1
Liu, Z1
Liu, AJ1
Wang, YX1
Wang, HG1
An, D1
Heng, B1
Xie, LH1
Duan, JL1
Liu, YQ1
Shen, J1
Yang, Y1
Kitamura, Y1
Iida, Y1
Abe, J1
Ueda, M1
Mifune, M1
Kasuya, F1
Ohta, M1
Igarashi, K1
Saito, Y1
Saji, H1

Other Studies

8 other studies available for n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine and Infarction, Middle Cerebral Artery

ArticleYear
Aromatase and neuroinflammation in rat focal brain ischemia.
    The Journal of steroid biochemistry and molecular biology, 2017, Volume: 174

    Topics: Animals; Aromatase; Brain; Chelating Agents; Ethylenediamines; Excitatory Amino Acid Antagonists; Hu

2017
Synergistic Interaction Between Zinc and Reactive Oxygen Species Amplifies Ischemic Brain Injury in Rats.
    Stroke, 2018, Volume: 49, Issue:9

    Topics: Animals; Antioxidants; Apoptosis; Biphenyl Compounds; Brain; Brain Ischemia; Chelating Agents; Ethyl

2018
Chelating intracellularly accumulated zinc decreased ischemic brain injury through reducing neuronal apoptotic death.
    Stroke, 2014, Volume: 45, Issue:4

    Topics: Animals; Apoptosis; Brain Ischemia; Chelating Agents; Cytosol; Ethylenediamines; Infarction, Middle

2014
Indomethacin preconditioning induces ischemic tolerance by modifying zinc availability in the brain.
    Neurobiology of disease, 2015, Volume: 81

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Carrier Proteins; Cell Death; Chelating Age

2015
Reduction of zinc accumulation in mitochondria contributes to decreased cerebral ischemic injury by normobaric hyperoxia treatment in an experimental stroke model.
    Experimental neurology, 2015, Volume: 272

    Topics: Analysis of Variance; Animals; Brain; Cholinesterase Inhibitors; Cytochromes c; Disease Models, Anim

2015
The Zinc Ion Chelating Agent TPEN Attenuates Neuronal Death/apoptosis Caused by Hypoxia/ischemia Via Mediating the Pathophysiological Cascade Including Excitotoxicity, Oxidative Stress, and Inflammation.
    CNS neuroscience & therapeutics, 2015, Volume: 21, Issue:9

    Topics: Animals; Apoptosis; Brain; Brain Ischemia; Cell Hypoxia; Chelating Agents; Disease Models, Animal; E

2015
Zinc contributes to acute cerebral ischemia-induced blood-brain barrier disruption.
    Neurobiology of disease, 2016, Volume: 95

    Topics: Animals; Blood-Brain Barrier; Brain Ischemia; Ethylenediamines; Infarction, Middle Cerebral Artery;

2016
Protective effect of zinc against ischemic neuronal injury in a middle cerebral artery occlusion model.
    Journal of pharmacological sciences, 2006, Volume: 100, Issue:2

    Topics: Animals; Calcium; Calcium Radioisotopes; Cell Culture Techniques; Cell Survival; Cells, Cultured; Ch

2006